An Update on Clinical Trials and Potential Therapeutic Strategies in T-Cell Acute Lymphoblastic Leukemia

Current therapies for T-cell acute leukemia are based on risk stratification and have greatly improved the survival rate for patients, but mortality rates remain high owing to relapsed disease, therapy resistance, or treatment-related toxicities/infection. Patients with relapsed disease continue to...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Janisha, Gao, Xueliang, Wang, Haizhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10139433/
https://www.ncbi.nlm.nih.gov/pubmed/37108359
http://dx.doi.org/10.3390/ijms24087201

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10139433/
https://www.ncbi.nlm.nih.gov/pubmed/37108359
http://dx.doi.org/10.3390/ijms24087201

Ejemplares similares